Search

Author/Creator Fishman, Ami

1. 2022-RA-1052-ESGO Low-risk endometrial cancer and no adjuvant treatment: do isolated tumor cells (ITC) have an effect on recurrence? An international multi-institutional comparative study between ITC and node-negative in sentinel lymph node biopsy. (20th October 2022)

Authors:
Cucinella, Giuseppe; Schivardi, Gabriella; Zhou, Xun Clare; Alhilli, Mariam; Wallace, Sumer; Wohlmuth, Christoph; Baiocchi, Glauco; Tokgozoglu, Nedim; Raspagliesi, Francesco; Buda, Alessandro; Zanagnolo, Vanna; Zapardiel, Ignacio; Jagasia, Nisha; Giuntoli, Robert; Glickman, Ariel; Peiretti, Miche...
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A132
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 2022-RA-998-ESGO Intermediate-risk endometrial cancer: isolated tumor cells (ITC) versus node-negative in sentinel lymph node mapping. An international multi-institutional comparative study. (20th October 2022)

Authors:
Cucinella, Giuseppe; Schivardi, Gabriella; Zhou, Xun Clare; Alhilli, Mariam; Wallace, Sumer; Wohlmuth, Christoph; Baiocchi, Glauco; Tokgozoglu, Nedim; Raspagliesi, Francesco; Buda, Alessandro; Zanagnolo, Vanna; Zapardiel, Ignacio; Jagasia, Nisha; Giuntoli, Robert; Glickman, Ariel; Peiretti, Miche...
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A127
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. BRCA1 is Expressed in Uterine Serous Carcinoma (USC) and Controls Insulin-Like Growth Factor I Receptor (IGF-IR) Gene Expression in USC Cell Lines. Issue 5 (1st June 2012)

Authors:
Amichay, Keren; Kidron, Debora; Attias-Geva, Zohar; Schayek, Hagit; Sarfstein, Rive; Fishman, Ami; Werner, Haim; Bruchim, Ilan
Journal:
International journal of gynecological cancer
Issue:
Volume 22:Issue 5(2012)
Page Start:
748
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Corrigendum to "DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer" [Canc. Lett. 501 224–233]. (1st June 2023)

Authors:
Moskovich, Dotan; Alfandari, Adi; Finkelshtein, Yael; Weisz, Avivit; Katzav, Aviva; Kidron, Debora; Edelstein, Evgeny; Veroslavski, Daniel; Perets, Ruth; Arbib, Nissim; Kadan, Yfat; Fishman, Ami; Lerer, Bernard; Ellis, Martin; Ashur-Fabian, Osnat
Journal:
Cancer letters
Issue:
Volume 563(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗